Back to Search
Start Over
Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.
- Source :
-
The American journal of cardiology [Am J Cardiol] 2002 Sep 15; Vol. 90 (6), pp. 628-30. - Publication Year :
- 2002
- Subjects :
- Abciximab
Aged
Cardiovascular Diseases mortality
Double-Blind Method
Endpoint Determination
Female
Follow-Up Studies
Humans
Male
Middle Aged
Predictive Value of Tests
Risk Factors
Survival Analysis
Treatment Outcome
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal therapeutic use
Cardiovascular Diseases therapy
Immunoglobulin Fab Fragments therapeutic use
Platelet Aggregation Inhibitors therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0002-9149
- Volume :
- 90
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- The American journal of cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 12231090
- Full Text :
- https://doi.org/10.1016/s0002-9149(02)02568-7